Accuray price to free cash flow ARAY

Market value divided by free cash flow over the last twelve months, since 2016.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 3.6×; Feb 2026
10-year median: 24.8×
10-year range: 3.6× to 136×
Peer median: 9.2×

Accuray's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Feb 2026, at 3.6×.

On the days it had one over the last ten years, its median was 24.8×, from 3.6× in Feb 2026 to 136× in Jan 2023.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.6×	3.6×	5.8×
2025	5.4×	5.4×	8.8×
2024	21.0×	21.0×	37.6×
2023	92.5×	85.2×	136×
2022	114×	5.8×	131×
2021	14.7×	7.0×	26.8×
2020	21.8×	15.1×	24.7×
2019	57.0×	45.1×	58.8×
2018	45.4×	24.1×	65.9×
2017	64.3×	56.9×	64.3×
2016	52.8×	16.0×	478×

Against its peers

Companies in Medical - Instruments & Supplies nearest Accuray's size, closest first, today.

Company	Price to free cash flow
ARAYAccuray	n/m
NEPHNephros	n/m
APTAlpha Pro Tech	9.7×
KEQUKewaunee Scientific	8.7×
Peer median	9.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Accuray

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.